{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:30:34Z","timestamp":1786404634020,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Hedgehog (Hh) signaling pathway plays an essential role in embryonic development, and its aberrant activation is associated with pancreatic cancer progression. However, the function of Suppressor of Fused (SUFU), a critical negative regulator of the Hh pathway, in pancreatic cancer has been poorly studied. In this study, we found that\n                    <jats:italic>SUFU<\/jats:italic>\n                    knockdown significantly inhibits pancreatic cancer cell growth, migration, and proliferation while inducing apoptosis. We identified a direct interaction between JOSD1 and SUFU, whereby JOSD1 stabilizes SUFU protein by inhibiting its ubiquitination and proteasomal degradation. Public database analyses revealed a positive correlation between\n                    <jats:italic>JOSD1<\/jats:italic>\n                    and\n                    <jats:italic>SUFU<\/jats:italic>\n                    expression in pancreatic cancer tissues, and immunofluorescence staining of clinical samples further showed that JOSD1 and SUFU are co-localized and expressed at higher levels in pancreatic cancer tissues compared with normal pancreatic tissues. Notably, SUFU regulates pancreatic cancer cell behavior through a non-canonical, Hh-independent mechanism. Depletion of either\n                    <jats:italic>JOSD1<\/jats:italic>\n                    or\n                    <jats:italic>SUFU<\/jats:italic>\n                    downregulated proliferation-related genes and upregulated apoptosis-related genes, thereby suppressing pancreatic cancer cell growth and promoting apoptosis, with these effects reversed by SUFU restoration. Consistently, silencing of\n                    <jats:italic>JOSD1<\/jats:italic>\n                    or\n                    <jats:italic>SUFU<\/jats:italic>\n                    significantly attenuates tumor growth and reduces Ki67 expression in vivo, whereas re-expression of SUFU in JOSD1-deficient tumors restores tumor growth and proliferation. Collectively, these findings highlight the functional importance of JOSD1-mediated SUFU stabilization in pancreatic cancer and suggest potential therapeutic strategies targeting this axis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08954-0","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:24:10Z","timestamp":1780669450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JOSD1-mediated stabilization of SUFU controls pancreatic cancer progression"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5152-8354","authenticated-orcid":false,"given":"Kai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3970-3789","authenticated-orcid":false,"given":"Jujin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2199-0149","authenticated-orcid":false,"given":"Changan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-6094","authenticated-orcid":false,"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-0245","authenticated-orcid":false,"given":"Liya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-574X","authenticated-orcid":false,"given":"Jiayin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"8954_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008\u201320.","journal-title":"Lancet"},{"key":"8954_CR2","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","volume":"22","author":"M Ilic","year":"2016","unstructured":"Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22:9694.","journal-title":"World J Gastroenterol"},{"key":"8954_CR3","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/ije\/dyx143","volume":"46","author":"L Buscail","year":"2017","unstructured":"Buscail L. Commentary: Pancreatic cancer: is the worst to come? Int J Epidemiol. 2017;46:1774\u20135.","journal-title":"Int J Epidemiol"},{"key":"8954_CR4","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.21037\/tcr.2018.10.19","volume":"7","author":"Z Fan","year":"2018","unstructured":"Fan Z, Fan K, Yang C, Huang Q, Gong Y, Cheng H, et al. Critical role of KRAS mutation in pancreatic ductal adenocarcinoma. Transl Cancer Res. 2018;7:1728\u201336.","journal-title":"Transl Cancer Res"},{"key":"8954_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201900631","volume":"15","author":"Y Pei","year":"2019","unstructured":"Pei Y, Chen L, Huang Y, Wang J, Feng J, Xu M, et al. Sequential targeting TGF-\u03b2 signaling and KRAS mutation increases therapeutic efficacy in pancreatic cancer. Small. 2019;15:e1900631.","journal-title":"Small"},{"key":"8954_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/or.2016.4820","volume":"36","author":"Y Mao","year":"2016","unstructured":"Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, et al. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K\/Akt pathway via Polo-like kinase 1. Oncol Rep. 2016;36:49\u201356.","journal-title":"Oncol Rep"},{"key":"8954_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7555\/JBR.30.20150107","volume":"30","author":"D Gu","year":"2016","unstructured":"Gu D, Schlotman KE, Xie J. Deciphering the role of hedgehog signaling in pancreatic cancer. J Biomed Res. 2016;30:353\u201360.","journal-title":"J Biomed Res"},{"key":"8954_CR8","doi-asserted-by":"publisher","first-page":"108107","DOI":"10.1016\/j.pharmthera.2022.108107","volume":"236","author":"D Quatannens","year":"2022","unstructured":"Quatannens D, Verhoeven Y, Van Dam P, Lardon F, Prenen H, Roeyen G, et al. Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacol Ther. 2022;236:108107.","journal-title":"Pharmacol Ther"},{"key":"8954_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature02009","volume":"425","author":"SP Thayer","year":"2003","unstructured":"Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425:851\u20136.","journal-title":"Nature"},{"key":"8954_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1083\/jcb.201004108","volume":"191","author":"H Tukachinsky","year":"2010","unstructured":"Tukachinsky H, Lopez LV, Salic A. A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol. 2010;191:415\u201328.","journal-title":"J Cell Biol"},{"key":"8954_CR11","first-page":"240","volume":"13","author":"M Dan","year":"2013","unstructured":"Dan M, Xiao-hua M, Jun G, Zhao-shen L. Expression and clinical significance of Shh, Gli1, Sufu, TAK1, p-TAK1 protein in pancreatic carcinoma. Chin J Pancreat Dis. 2013;13:240\u20133.","journal-title":"Chin J Pancreat Dis"},{"key":"8954_CR12","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3892\/ijo.2016.3753","volume":"49","author":"Q Xu","year":"2016","unstructured":"Xu Q, Gao J, Li Z. Identification of a novel alternative splicing transcript variant of the suppressor of fused: relationship with lymph node metastasis in pancreatic ductal adenocarcinoma. Int J Oncol. 2016;49:2611\u20139.","journal-title":"Int J Oncol"},{"key":"8954_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104618","volume":"25","author":"K Fang","year":"2022","unstructured":"Fang K, Du S, Shen D, Xiong Z, Jiang K, Liang D, et al. SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo\/YAP pathway. iScience. 2022;25:104618.","journal-title":"iScience"},{"key":"8954_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1042\/BCJ20220439","volume":"480","author":"BD Paradise","year":"2023","unstructured":"Paradise BD, Gainullin VG, Almada LL, Sigafoos AN, Sen S, Vera RE, et al. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. Biochem J. 2023;480:1199\u2013216.","journal-title":"Biochem J"},{"key":"8954_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41418-022-01073-1","volume":"30","author":"Y Deng","year":"2023","unstructured":"Deng Y, Peng D, Xiao J, Zhao Y, Ding W, Yuan S, et al. Inhibition of the transcription factor ZNF281 by SUFU to suppress tumor cell migration. Cell Death Differ. 2023;30:702\u201315.","journal-title":"Cell Death Differ"},{"key":"8954_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/onc.2008.403","volume":"28","author":"S Yue","year":"2009","unstructured":"Yue S, Chen Y, Cheng SY. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway. Oncogene. 2009;28:492\u20139.","journal-title":"Oncogene"},{"key":"8954_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03487-0","volume":"12","author":"Z Yan","year":"2021","unstructured":"Yan Z, Cheng M, Hu G, Wang Y, Zeng S, Huang A, et al. Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth. Cell Death Dis. 2021;12:199.","journal-title":"Cell Death Dis"},{"key":"8954_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10555-017-9697-6","volume":"36","author":"A Mofers","year":"2017","unstructured":"Mofers A, Pellegrini P, Linder S, D\u2019Arcy P. Proteasome-associated deubiquitinases and cancer. Cancer Metastasis Rev. 2017;36:635\u201353.","journal-title":"Cancer Metastasis Rev"},{"key":"8954_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcancer.2019.12.013","volume":"68","author":"H Yang","year":"2021","unstructured":"Yang H, Chen X, Li K, Cheaito H, Yang Q, Wu G, et al. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. Semin Cancer Biol. 2021;68:105\u201322.","journal-title":"Semin Cancer Biol"},{"key":"8954_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbamcr.2004.10.003","volume":"1695","author":"AY Amerik","year":"2004","unstructured":"Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim et Biophys Acta. 2004;1695:189\u2013207.","journal-title":"Biochim et Biophys Acta"},{"key":"8954_CR21","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1074\/jbc.M110.177360","volume":"286","author":"SD Weeks","year":"2011","unstructured":"Weeks SD, Grasty KC, Hernandez-Cuebas L, Loll PJ. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity. J Biol Chem. 2011;286:4555\u201365.","journal-title":"J Biol Chem"},{"key":"8954_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbadis.2011.10.010","volume":"1822","author":"MN La\u00e7o","year":"2012","unstructured":"La\u00e7o MN, Oliveira CR, Paulson HL, Rego AC. Compromised mitochondrial complex II in models of Machado\u2013Joseph disease. Biochim et Biophys Acta (BBA)-Mol Basis Dis. 2012;1822:139\u201349.","journal-title":"Biochim et Biophys Acta (BBA)-Mol Basis Dis"},{"key":"8954_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jnnp-2018-319200","volume":"90","author":"EP de Mattos","year":"2019","unstructured":"de Mattos EP, Musskopf MK, Leotti VB, Saraiva-Pereira ML, Jardim LB. Genetic risk factors for modulation of age at onset in Machado-Joseph disease\/spinocerebellar ataxia type 3: a systematic review and meta-analysis. J Neurol, Neurosurg Psychiatry. 2019;90:203\u201310.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"8954_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/bip.21210","volume":"91","author":"G Nicastro","year":"2009","unstructured":"Nicastro G, Masino L, Esposito V, Menon RP, De Simone A, Fraternali F, et al. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites. Biopolymers. 2009;91:1203\u201314.","journal-title":"Biopolymers"},{"key":"8954_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/B978-0-444-51892-7.00027-9","volume":"103","author":"H Paulson","year":"2012","unstructured":"Paulson H. Machado\u2013Joseph disease\/spinocerebellar ataxia type 3. Handb Clin Neurol. 2012;103:437\u201349.","journal-title":"Handb Clin Neurol"},{"key":"8954_CR26","doi-asserted-by":"publisher","first-page":"21369","DOI":"10.18632\/oncotarget.4128","volume":"6","author":"F Ge","year":"2015","unstructured":"Ge F, Chen W, Qin J, Zhou Z, Liu R, Liu L, et al. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Kr\u00fcppel-like factor 5 (KLF5). Oncotarget. 2015;6:21369.","journal-title":"Oncotarget"},{"key":"8954_CR27","doi-asserted-by":"publisher","first-page":"26436","DOI":"10.1074\/jbc.M803692200","volume":"283","author":"BJ Winborn","year":"2008","unstructured":"Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, Williams AJ, et al. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem. 2008;283:26436\u201343.","journal-title":"J Biol Chem"},{"key":"8954_CR28","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/onc.2013.512","volume":"33","author":"J Sacco","year":"2014","unstructured":"Sacco J, Yau T, Darling S, Patel V, Liu H, Urbe S, et al. The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells. Oncogene. 2014;33:4265\u201372.","journal-title":"Oncogene"},{"key":"8954_CR29","doi-asserted-by":"publisher","first-page":"e2000733","DOI":"10.1371\/journal.pbio.2000733","volume":"14","author":"H Liu","year":"2016","unstructured":"Liu H, Li X, Ning G, Zhu S, Ma X, Liu X, et al. The Machado\u2013Joseph disease deubiquitinase ataxin-3 regulates the stability and apoptotic function of p53. PLoS Biol. 2016;14:e2000733.","journal-title":"PLoS Biol"},{"key":"8954_CR30","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.15252\/embj.201695151","volume":"36","author":"A Pfeiffer","year":"2017","unstructured":"Pfeiffer A, Luijsterburg MS, Acs K, Wiegant WW, Helfricht A, Herzog LK, et al. Ataxin-3 consolidates the MDC 1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF 4. EMBO J. 2017;36:1066\u201383.","journal-title":"EMBO J"},{"key":"8954_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cancergen.2017.03.008","volume":"212","author":"GN Souza","year":"2017","unstructured":"Souza GN, Kersting N, Gon\u00e7alves TA, Pacheco DLO, Saraiva-Pereira M-L, Camey SA, et al. Cancer in Machado\u2013Joseph disease patients\u2014low frequency as a cause of death. Cancer Genet. 2017;212:19\u201323.","journal-title":"Cancer Genet"},{"key":"8954_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/vim.2017.0015","volume":"30","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang L, Zhang Y, Zhao P, Qian L, Yuan Y, et al. JOSD1 Negatively regulates type-I interferon antiviral activity by deubiquitinating and stabilizing SOCS1. Viral Immunol. 2017;30:342\u20139.","journal-title":"Viral Immunol"},{"key":"8954_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41418-019-0339-0","volume":"27","author":"X Wu","year":"2020","unstructured":"Wu X, Luo Q, Zhao P, Chang W, Wang Y, Shu T, et al. JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death Differ. 2020;27:55\u201370.","journal-title":"Cell Death Differ"},{"key":"8954_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29857-6","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, Li Y, Yuan Q, Tang S, Guo S, Zhang Y, et al. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. Nat Commun. 2022;13:2169.","journal-title":"Nat Commun"},{"key":"8954_CR35","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3748\/wjg.v27.i18.2105","volume":"27","author":"F Polani","year":"2021","unstructured":"Polani F, Grierson PM, Lim KH. Stroma-targeting strategies in pancreatic cancer: past lessons, challenges and prospects. World J Gastroenterol. 2021;27:2105\u201321.","journal-title":"World J Gastroenterol"},{"key":"8954_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/apm-23-560","volume":"13","author":"C Friedes","year":"2024","unstructured":"Friedes C, Butala AA. Palliative radiotherapy for pancreatic cancer. Ann Palliat Med. 2024;13:1\u20134.","journal-title":"Ann Palliat Med"},{"key":"8954_CR37","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1242\/jcs.112.23.4437","volume":"112","author":"DM Stone","year":"1999","unstructured":"Stone DM, Murone M, Luoh S-M, Ye W, Armanini MP, Gurney A, et al. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci. 1999;112:4437\u201348.","journal-title":"J Cell Sci"},{"key":"8954_CR38","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1242\/dev.127.18.4001","volume":"127","author":"N M\u00e9thot","year":"2000","unstructured":"M\u00e9thot N, Basler K. Suppressor of fused opposes hedgehog signal transduction by impeding nuclear accumulation of the activator form of Cubitus interruptus. Development. 2000;127:4001\u201310.","journal-title":"Development"},{"key":"8954_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03339-0","volume":"9","author":"P Infante","year":"2018","unstructured":"Infante P, Faedda R, Bernardi F, Bufalieri F, Lospinoso Severini L, Alfonsi R, et al. Itch\/\u03b2-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis. Nat Commun. 2018;9:976.","journal-title":"Nat Commun"},{"key":"8954_CR40","doi-asserted-by":"crossref","unstructured":"Han B, Wang Y, Yue S, Zhang YH, Kuang L, Gao BB, et al. Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis. JCI insight. 2024;9:e176044.","DOI":"10.1172\/jci.insight.176044"},{"key":"8954_CR41","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.15252\/embj.201593374","volume":"35","author":"M Raducu","year":"2016","unstructured":"Raducu M, Fung E, Serres S, Infante P, Barberis A, Fischer R, et al. SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. EMBO J. 2016;35:1400\u201316.","journal-title":"EMBO J"},{"key":"8954_CR42","doi-asserted-by":"publisher","first-page":"120.","DOI":"10.1038\/s41420-021-00484-2","volume":"7","author":"B Han","year":"2021","unstructured":"Han B, Sun Z, Yu T, Wang Y, Kuang L, Li T, et al. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway. Cell Death Discov. 2021;7:120.","journal-title":"Cell Death Discov"},{"key":"8954_CR43","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ncb3616","volume":"19","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang LS, Toombs J, Kuo YC, Piazza JT, Tuladhar R, et al. Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor. Nat Cell Biol. 2017;19:1226\u201336.","journal-title":"Nat Cell Biol"},{"key":"8954_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3608","volume":"4","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Fu L, Qi X, Zhang Z, Xia Y, Jia J, et al. Structural insight into the mutual recognition and regulation between suppressor of fused and Gli\/Ci. Nat Commun. 2013;4:2608.","journal-title":"Nat Commun"},{"key":"8954_CR45","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.7150\/thno.83676","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Peng J, Xia Y, Pan C, Li Y, Gu W, et al. Sufu limits sepsis-induced lung inflammation via regulating phase separation of TRAF6. Theranostics. 2023;13:3761\u201380.","journal-title":"Theranostics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08954-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:16:10Z","timestamp":1786403770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08954-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8954"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08954-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"705"}}